Swine Flu News and Research RSS Feed - Swine Flu News and Research Twitter

Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.
Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

SUGAR-based adjuvants from Australia are boosting the effectiveness of vaccines to target some of the world’s deadliest diseases. [More]
Researchers make successful vaccine formulation that targets proteins linked to Alzheimer’s disease

Researchers make successful vaccine formulation that targets proteins linked to Alzheimer’s disease

With more than 7.5 million new cases of Alzheimer’s disease a year, the race to find a vaccine and effective treatment for dementia is growing by the day. [More]
Researchers identify exact origin of 2009 swine H1N1 flu pandemic

Researchers identify exact origin of 2009 swine H1N1 flu pandemic

The 2009 swine H1N1 flu pandemic — responsible for more than 17,000 deaths worldwide — originated in pigs from a very small region in central Mexico, a research team headed by investigators at the Icahn School of Medicine at Mount Sinai is reporting. [More]
Study highlights potential emergence of new swine flu strains

Study highlights potential emergence of new swine flu strains

The wide diversity of flu in pigs across multiple continents, mostly introduced from humans, highlights the significant potential of new swine flu strains emerging, according to a study to be published in eLife. [More]
Interdisciplinary researchers to explore ethical issues of pregnant women during Zika crisis

Interdisciplinary researchers to explore ethical issues of pregnant women during Zika crisis

The emerging Zika virus epidemic is bringing to light a longstanding ethical challenge in medical research: the inclusion of pregnant women. With new funding from the Wellcome Trust, an interdisciplinary team of scholars will focus on issues of ethics and research in pregnancy and women of reproductive age, beginning with the current Zika context and later expanding to general public health research. [More]
UGA and Sanofi Pasteur researchers develop new H1N1 influenza vaccine

UGA and Sanofi Pasteur researchers develop new H1N1 influenza vaccine

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. [More]
CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the China Food and Drug Administration issued the new drug certificate and production license for its Enterovirus 71 ("EV71") vaccine. [More]
Four journalists from China and India win 2016 EurekAlert! Fellowships for International Science Reporters

Four journalists from China and India win 2016 EurekAlert! Fellowships for International Science Reporters

Four early-career journalists from China and India have emerged from the fiercest competition to date to win the 2016 EurekAlert! Fellowships for International Science Reporters. [More]
Sinovac gets approval to begin clinical trials on Sabin Inactivated Polio Vaccine candidate

Sinovac gets approval to begin clinical trials on Sabin Inactivated Polio Vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin Inactivated Polio Vaccine (or "sIPV") candidate. [More]
Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted by the China Food and Drug Administration in January 2013. [More]
RE.WORK showcases future technology and innovations in deep learning software

RE.WORK showcases future technology and innovations in deep learning software

The future of technological innovation is a broad topic with endless opportunities in every scientific field. RE.WORK’s two most recent concurrent conferences ‘RE.WORK: Future Technology’ and ‘RE.WORK: Deep Learning’, in part focussed on putting healthcare in the context of the wider technological revolution. [More]
Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots. [More]
TSRI, Janssen collaborate to find universal flu vaccine

TSRI, Janssen collaborate to find universal flu vaccine

Scientists from The Scripps Research Institute and the Janssen Pharmaceutical Companies of Johnson & Johnson have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots. [More]
NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide drug development program. [More]
Sinovac Biotech releases results of 2015 Annual General Meeting of Shareholders held in Beijing, PRC

Sinovac Biotech releases results of 2015 Annual General Meeting of Shareholders held in Beijing, PRC

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC. [More]
New dissolvable microneedle patch could make flu vaccination easier, safer and less painful

New dissolvable microneedle patch could make flu vaccination easier, safer and less painful

Flu vaccines delivered using microneedles that dissolve in the skin can protect people against infection even better than the standard needle-delivered vaccine, according to new research published in Biomaterials. The authors of the study, from Osaka University in Japan, say their dissolvable patch - the only vaccination system of its kind - could make vaccination easier, safer and less painful. [More]
UM SOM researcher uncovers new details about the body's response to flu virus

UM SOM researcher uncovers new details about the body's response to flu virus

The flu virus can be lethal. But what is often just as dangerous is the body's own reaction to the invader. This immune response consists of an inflammatory attack, meant to kill the virus. But if it gets too aggressive, this counterattack can end up harming the body's own tissues, causing damage that can lead to death. [More]
St. Michael's Hospital researchers find novel method to combat flu virus

St. Michael's Hospital researchers find novel method to combat flu virus

The flu kills hundreds of thousands of people around the world every year, yet there is essentially only one class of drugs to fight the ever-changing virus. Cases of flu resistant to this class of drugs have already been reported and researchers worry a completely new strain of flu could evolve, leading to a pandemic like the one in 1918 that killed approximately 50 million people. [More]
WHO calls on experts, social media to follow best practices in naming new human infectious diseases

WHO calls on experts, social media to follow best practices in naming new human infectious diseases

WHO today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people. [More]
WHO issues best practices for naming new human infectious diseases

WHO issues best practices for naming new human infectious diseases

The World Health Organization (WHO) today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people... [More]
Advertisement
Advertisement